ACHV Q3 2022 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

ACHVAchieve Life Sciences, Inc.

$227M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-1.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$829,000

Balance Sheet

Total Assets

$24M

Total Liabilities

$23M

Stockholders' Equity

$1M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$13M	-$7M	-88.8%
Net Income	-$13M	-$7M	-95.4%